Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates

Transfusion. 2013 May;53(5):1143-4. doi: 10.1111/trf.12153.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Coagulation Factors / adverse effects*
  • Female
  • Hemophilia A*
  • Humans
  • Male
  • Parvoviridae Infections / blood*
  • Parvoviridae Infections / transmission*
  • Parvovirus B19, Human / isolation & purification*

Substances

  • Blood Coagulation Factors